The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis
Abstract
Methamphetamine (METH) is a drug of abuse that has long been known to damage monoaminergic systems in the mammalian brain. Recent reports have provided conclusive evidence that METH can cause neuropathological changes in the rodent brain via apoptotic mechanisms akin to those reported in various models of neuronal death. The purpose of this review is to provide an interim account for a role of oxygen‐based radicals and the participation of transcription factors and the involvement of cell death genes in METH‐induced neurodegeneration. We discuss data suggesting the participation of endoplasmic reticulum and mitochondria‐mediated activation of caspase‐dependent and ‐independent cascades in the manifestation of METH‐induced apoptosis. Studies that use more comprehensive approaches to gene expression profiling should allow us to draw more instructive molecular portraits of the complex plastic and degenerative effects of this drug.—Cadet, J. L., Jayanthi, S., Deng, X. Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17, 1775–1788 (2003)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Methamphetamine (MA) is a psychostimulant that when used regularly is associated with harms such as injecting and sexual risk-taking behaviour, symptoms of mental ill health (eg, psychosis, aggression, depression and/or anxiety), psychomotor, social and cognitive impairment, criminal activity and sometimes death caused by overdose.1–7”
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K. N., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,913
Caspases: the executioners of apoptosis
Cohen, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,737
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Peroxynitrite oxidation of sulfhydryls.
Radí, R., Beckman, J. S., Bush, K., & Freeman, B. Α. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,492
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,125
Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H. E., Stevens, J. L., & Ron, D. (1998) · Genes & Development · doi:10.1101/gad.12.7.982 · Cited by 2,039
Flagged first, then by citations
Research works printed but not linked: 1
- Cadet J. L., 2003, Gluamate and Addiction, 201
Cited by
Sorted by citations
Items 101–200 of 286
Huang, Y.-N., Wu, C., Lin, T.-C., & Wang, J. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.06.021 · Cited by 47
Cheng, R., Etchegaray, M., & Meck, W. H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.002 · Cited by 46
Segal, D. S., & Kuczenski, R. T. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300865 · Cited by 47
Achat‐Mendes, C., Anderson, K. L., & Itzhak, Y. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301119 · Cited by 45
Xu, X., Huang, E., Luo, B., Cai, D., Zhao, X., Luo, Q., Jin, Y., Chen, L., Wang, Q., Liu, C., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701460rrr · Cited by 46
Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents
Chou, J., Luo, Y., Kuo, C.-C., Powers, K., Shen, H., Harvey, B. K., Hoffer, B. J., & Wang, Y. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.044 · Cited by 45
Durose, W. W., Phansuwan‐Pujito, P., Govitrapong, P., & Chetsawang, B. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00680.x · Cited by 44
Salo, R. E., Buonocore, M. H., Leamon, M. H., Natsuaki, Y., Waters, C., Moore, C. D., Galloway, G. P., & NORDAHL, T. E. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.015 · Cited by 44
Ren, Q., Zhang, J., Ma, M., Fujita, Y., Wu, J., & Hashimoto, K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3221-7 · Cited by 44
Iwazaki, T., McGregor, I. S., & Matsumoto, I. (2007) · PROTEOMICS · doi:10.1002/pmic.200600595 · Cited by 43
Cherner, M., Bousman, C., Everall, I., Barron, D. S., Letendre, S. L., Vaida, F., Atkinson, J. H., Heaton, R. K., Grant, I., & THE HNRC GROUP (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710000779 · Cited by 42
Psychoproteomic Analysis of Rat Cortex Following Acute Methamphetamine Exposure
Kobeissy, F. H., Warren, M. W., Ottens, A. K., Sadasivan, S., Zhang, Z., Gold, M. S., & Wang, K. (2008) · Journal of Proteome Research · doi:10.1021/pr800029h · Cited by 42
Cass, W. A., Peters, L. E., Harned, M. E., & Seroogy, K. B. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.024 · Cited by 44
Shin, E., Duong, C. X., Nguyen, X.-K. T., Bing, G., Bach, J., Park, D. H., Nakayama, K. I., Ali, S. F., Kanthasamy, A. G., Cadet, J. L., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.03.022 · Cited by 41
Self-citationMethamphetamine use and oral health-related quality of life
Mukherjee, A., Dye, B. A., Clague, J., Belin, T. R., & Shetty, V. (2018) · Quality of Life Research · doi:10.1007/s11136-018-1957-6 · Cited by 41
Ghanbari, F., Khaksari, M., Vaezi, G., Hojati, V., & Shiravi, A. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1218-8 · Cited by 41
Cadet, J. L., Krasnova, I. N., Ladenheim, B., Cai, N.-S., McCoy, M. T., & Atianjoh, F. E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9026-0 · Cited by 40
Self-citationSuwanjang, W., Phansuwan‐Pujito, P., Govitrapong, P., & Chetsawang, B. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00731.x · Cited by 40
Kawasaki, T., Ishihara, K., Ago, Y., Nakamura, S., Itoh, S., Baba, A., & Matsuda, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.012 · Cited by 40
Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum
Wu, P.-H., Shen, Y., Wang, Y.-H., Chi, C., & Yen, J. (2006) · Toxicology · doi:10.1016/j.tox.2006.06.015 · Cited by 40
Theodore, S., Cass, W. A., & Maragos, W. F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.009 · Cited by 40
Braren, S. H., Drapala, D., Tulloch, I. K., & Serrano, P. A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00438 · Cited by 39
Carati, C., & Schenk, S. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.010 · Cited by 40
Cocaine increases endoplasmic reticulum stress protein expression in striatal neurons
Shin, E. H., Bian, S., Shim, Y., Rahman, M. A., Chung, K. T., Kim, J. Y., Wang, J. Q., & Choe, E. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.013 · Cited by 39
Kuhn, F. T., Roversi, K., Antoniazzi, C. T. D. D., Pase, C. S., Trevizol, F., Barcelos, R. C. S., Dias, V. T., Roversi, K., Boufleur, N., Benvegnú, D. M., et al. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.06.001 · Cited by 38
Methamphetamine-induced locomotor changes are dependent on age, dose and genotype
Good, R. L., & Radcliffe, R. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.004 · Cited by 38
Pereira, F. C., Lourenço, E. S., Borges, F., Morgadinho, T., Ribeiro, C., Macedo, T. R. A., & Ali, S. F. (2006) · Synapse · doi:10.1002/syn.20285 · Cited by 37
Xi, Z., Kleitz‐Nelson, H. K., Deng, X., Ladenheim, B., Peng, X., Li, X., Gardner, E. L., Stein, E. A., & Cadet, J. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.060 · Cited by 36
Self-citationTocharus, J., Chongthammakun, S., & Govitrapong, P. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.036 · Cited by 36
Buchanan, J. B., Sparkman, N. L., & Johnson, R. W. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-82 · Cited by 35
Iwazaki, T., McGregor, I. S., & Matsumoto, I. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.02.025 · Cited by 35
Li, S., Yan, S., Bao, Y., Lian, Z., Qu, Z., Ya-ping, W., & Liu, Z. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2335 · Cited by 34
Is brain gliosis a characteristic of chronic methamphetamine use in the human?
Tong, J., Fitzmaurice, P. S., Furukawa, Y., Schmunk, G. A., Wickham, D. J., Ang, L.-C., Sherwin, A. L., McCluskey, T., Boileau, I., & Kish, S. J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.015 · Cited by 35
Kuczenski, R. T., Segal, D. S., Melega, W. P., Laćan, G., & McCunney, S. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.73 · Cited by 30
McCallum, G. P., Wong, A. W., & Wells, P. G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2946 · Cited by 33
Systems-Scale Analysis Reveals Pathways Involved in Cellular Response to Methamphetamine
Sun, L., Li‐Byarlay, H., Seufferheld, M. J., Walters, K. R., Margam, V. M., Jannasch, A., Diaz, N., Riley, C. P., Sun, W., Li, Y. F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018215 · Cited by 34
Shahidi, ., Komaki, A., Sadeghian, R., & Asl, S. S. (2019) · The Journal of Physiological Sciences · doi:10.1007/s12576-019-00660-1 · Cited by 33
Leventelis, C., Goutzourelas, N., Kortsinidou, A., Spanidis, Y., Toulia, G., Kampitsi, A., Tsitsimpikou, C., Stagos, D., Veskoukis, A. S., & Kouretas, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9417048 · Cited by 38
Hadizadeh-Bazaz, M., Vaezi, G., Khaksari, M., & Hojati, V. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.03.011 · Cited by 32
Hagiwara, H., Iyo, M., & Hashimoto, K. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.010 · Cited by 32
Reviriego, F., Rodrı́guez-Franco, M. I., Navarro, P., García‐España, E., Liu‐González, M., Verdejo, B., & Doménech‐Carbó, A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064657h · Cited by 32
Huang, Y.-N., Wang, J.-Y., Lee, C., Lin, C., Lai, C.-C., & Wang, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.036 · Cited by 31
Role of CXCR1 and Interleukin-8 in Methamphetamine-Induced Neuronal Apoptosis
Du, S., Zhang, W., Yue, X., Luo, X., Tan, X.-H., Liu, C., Qiao, D., & Wang, H. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00230 · Cited by 30
Omonijo, O., Wongprayoon, P., Ladenheim, B., McCoy, M. T., Govitrapong, P., Jayanthi, S., & Cadet, J. L. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.10.008 · Cited by 30
Self-citationCadet, J. L., Brannock, C., Ladenheim, B., McCoy, M. T., Beauvais, G., Hodges, A. B., Lehrmann, E., Wood, W. H., Becker, K. G., & Krasnova, I. N. (2010) · Dose-Response · doi:10.2203/dose-response.10-011.cadet · Cited by 28
Self-citationReviriego, F., Navarro, P., García‐España, E., Albelda, M. T., Frias, J. C., Doménech‐Carbó, A., Yunta, M. J. R., Costa, R. D., & Ortı́, E. (2008) · Organic Letters · doi:10.1021/ol801732t · Cited by 28
Marques, E. M. R., Vasconcelos, F., Rolo, M. R., Pereira, F. C., Silva, A. P., Macedo, T. R. A., & Ribeiro, C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.041 · Cited by 27
Anderson, K. L., & Itzhak, Y. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.021 · Cited by 28
Protective effects of interferon-γ against methamphetamine-induced neurotoxicity
Hozumi, H., Asanuma, M., Miyazaki, I., Fukuoka, S., Kikkawa, Y., Kimoto, N., Kitamura, Y., Sendo, T., Kita, T., & Gomita, Y. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.01.005 · Cited by 28
Killinger, B. A., Shah, M. M., & Moszczyńska, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12496 · Cited by 27
The role of hippocampal adult neurogenesis in methamphetamine addiction
Takashima, Y., & Mandyam, C. D. (2017) · Brain Plasticity · doi:10.3233/bpl-170058 · Cited by 27
Andres, M. A., Cooke, I. M., Bellinger, F., Berry, M., Zaporteza, M. M., Rueli, R. H., Barayuga, S. M., & Chang, L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13104 · Cited by 26
Tsuji, T., Asanuma, M., Miyazaki, I., Miyoshi, K., & Ogawa, N. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9863-x · Cited by 27
Nader, J., Rapino, C., Gennequin, B., Chavant, F., Francheteau, M., Makriyannis, A., Duranti, A., Maccarrone, M., Solinas, M., & Thiriet, N. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.014 · Cited by 27
Methamphetamine-induced apoptosis in glial cells examined under marker-free imaging modalities
D’Brant, L. Y., Desta, H., Khoo, T. C., Sharikova, A. V., Mahajan, S. D., & Khmaladze, A. T. (2019) · Journal of Biomedical Optics · doi:10.1117/1.jbo.24.4.046503 · Cited by 26
Reiner, D. J., Yu, S., Shen, H., He, Y., Bae, E. C., & Wang, Y. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9413-4 · Cited by 25
Chen, X., Qiu, F. X., Zhao, X., Lu, J., Tan, X.-H., Xu, J., Chen, C., Zhang, F., Liu, C., Qiao, D., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00559 · Cited by 24
Subu, R., Jayanthi, S., & Cadet, J. L. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02844-w · Cited by 25
Self-citationKuroda, K. O., Ornthanalai, V. G., Kato, T., & Murphy, N. P. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.169 · Cited by 25
Zhao, X., Lu, J., Chen, X., Gao, Z., Zhang, C., Chen, C., Qiao, D., & Wang, H. (2021) · The FASEB Journal · doi:10.1096/fj.202100188r · Cited by 24
Kerdsan-Phusan, W., Thanoi, S., & Nudmamud‐Thanoi, S. (2009) · BioMed Research International · doi:10.1155/2009/329631 · Cited by 24
García‐Cabrerizo, R., & García-Fuster, M. J. (2017) · Addiction Biology · doi:10.1111/adb.12593 · Cited by 24
Ji, J.-S., McDermott, J. L., & Dluzen, D. E. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01581.x · Cited by 24
ElAli, A., Urrutia, A. A., Rubio‐Araiz, A., Hernández‐Jiménez, M., Colado, M. I., Doeppner, T. R., & Hermann, D. M. (2012) · Stroke · doi:10.1161/strokeaha.111.648923 · Cited by 23
An Overview of Methamphetamine-induced Psychotic Syndromes
Zorick, T. S., Rad, D., Rim, C., & TSUANG, J. W. (2008) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318066d5e0 · Cited by 23
Horio, M., Kohno, M., Fujita, Y., Ishima, T., Inoue, R., Mori, H., & Hashimoto, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035494 · Cited by 23
BMP7 reduces synergistic injury induced by methamphetamine and ischemia in mouse brain
Shen, H., Luo, Y., Kuo, C.-C., & Wang, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.052 · Cited by 22
Seminerio, M. J., Kaushal, N., Shaikh, J., Huber, J. D., Coop, A., & Matsumoto, R. R. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.023 · Cited by 22
Zhang, X., Dong, F., Mayer, G. E., Bruch, D. C., Ren, J. T., & Culver, B. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.059 · Cited by 22
Namiki, M., Mori, T., Sawaguchi, T., Ito, S., & Suzuki, T. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj05004x · Cited by 22
Diwakarla, S., Nagley, P., Hughes, M. L. R., Chen, B., & Beart, P. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8490-7 · Cited by 21
Horner, K. A., Westwood, S. C., Hanson, G. R., & Keefe, K. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106856 · Cited by 20
Dluzen, D. E., & Salvaterra, T. J. (2005) · Neuroendocrinology · doi:10.1159/000090983 · Cited by 20
He, C., He, Q., Deng, C., Shi, L., Fu, Y., Cao, H., & Cheng, J. (2010) · Synthetic Metals · doi:10.1016/j.synthmet.2010.11.038 · Cited by 20
Methods in Drug Abuse Models: Comparison of Different Models of Methamphetamine Paradigms
Kobeissy, F. H., Mitzelfelt, J. D., Fishman, I., Morgan, D., Gaskins, R. B., Zhang, Z., Gold, M. S., & Wang, K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-458-2_17 · Cited by 20
Leung, K.-P., Qu, Y.-H., Qiao, D., Xie, W., Li, D., XU, J.-T., Wang, H., & Yue, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2572 · Cited by 20
Schiavone, S., Neri, M., Mhillaj, E., Pomara, C., Trabace, L., & Turillazzi, E. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.06.002 · Cited by 20
Yang, L., Guo, N., Fan, W., Ni, C., Huang, M., Bai, L., Zhang, L., Zhang, X., Wen, Y., Li, Y., et al. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.03.006 · Cited by 19
Neuroprotective strategies in drug abuse‐evoked encephalopathy
Virmani, A., Ali, S. F., & BINIENDA, Z. K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05171.x · Cited by 19
Hodges, A. B., Ladenheim, B., McCoy, M. T., Beauvais, G., Cai, N.-S., Krasnova, I. N., & Cadet, J. L. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017344 · Cited by 19
Self-citationProtective Effect of Sauchinone on Methamphetamine-Induced Neurotoxicity in Mice
Jang, E. Y., Park, K. A., Lee, J. R., Yang, C. H., & Hwang, M. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11207sc · Cited by 19
Methamphetamine induces DNA damage in specific regions of the female rat brain
Johnson, Z., Venters, J. R., Guarraci, F. A., & Zewail‐Foote, M. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12404 · Cited by 19
Zhu, R., Yang, T., Kobeissy, F. H., Mouhieddine, T. H., Raad, M., Nokkari, A., Gold, M. S., Wang, K., & Mechref, Y. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151034 · Cited by 19
Butler, B., Gamble‐George, J., Prins, P., North, A., Clarke, J. T., & Khoshbouei, H. (2014) · PubMed · Cited by 19
Garmabi, B., Mohaddes, R., Rezvani, F., Mohseni, F., Khastar, H., & Khaksari, M. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102137 · Cited by 18
Sex-related differences in striatal dopaminergic system after traumatic brain injury
Xu, X., Cao, S., Chao, H., Liu, Y., & Ji, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.010 · Cited by 18
Irie, Y., Saeki, M., Tanaka, H., Kanemura, Y., Otake, S., Ozono, Y., Nagai, T., Kondo, Y., Kudo, K., Kamisaki, Y., et al. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1207-5 · Cited by 18
Scheidweiler, K. B., Barnes, A. J., & Huestis, M. A. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.11.001 · Cited by 18
KOIKE, K., Hashimoto, K., Fukami, G., Okamura, N., ZHANG, L., Ohgake, S., KOIZUMI, H., Matsuzawa, D., KAWAMURA, N., & Shimizu, E. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.10.015 · Cited by 18
Natural Products in Modulating Methamphetamine-Induced Neuronal Apoptosis
Zeng, Y., Chen, Y., Zhang, S., Ren, H., Xia, J., Liu, M., Shan, B., & Ren, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.805991 · Cited by 17
Hadamitzky, M., McCunney, S. J., Markou, A., & Kuczenski, R. T. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2713-1 · Cited by 18
Nitric Oxide (NO) Signaling as a Potential Therapeutic Modality Against Psychostimulants
Liddie, S., Balda, M. A., & Itzhak, Y. (2013) · Current Pharmaceutical Design · doi:10.2174/138161281940131209144527 · Cited by 17
Pan, A. L., Hasalliu, E., Hasalliu, M., & Angulo, J. A. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00177-1 · Cited by 17
Weaver, J. M. R., Yang, Y., Purvis, R. S., Weatherwax, T., Rosen, G. M., & Liu, K. J. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.12.023 · Cited by 17
Coutinho, A., Flynn, C., Burdo, T. H., Mervis, R. F., & Fox, H. S. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9113-7 · Cited by 16
Kobeissy, F. H., Shakkour, Z., Hayek, S. E., Mohamed, W. M. Y., Gold, M. S., & Wang, K. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01886-8 · Cited by 18
Cocaine induces the expression of homer 1b/c, homer 3a/b, and hsp 27 proteins in rat cerebellum
Dietrich, J., Arpin‐Bott, M., Kao, D., Dirrig‐Grosch, S., Aunis, D., & Zwiller, J. (2007) · Synapse · doi:10.1002/syn.20412 · Cited by 16
Suwanjang, W., Phansuwan‐Pujito, P., Govitrapong, P., & Chetsawang, B. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.066 · Cited by 16
Methamphetamine regulates βAPP processing in human neuroblastoma cells
Shukla, M., Maitra, S., Hernandez, J., Govitrapong, P., & Vincent, B. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.023 · Cited by 16
Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration
Harvey, B. K., Chou, J., Shen, H., Hoffer, B. J., & Wang, Y. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.02.003 · Cited by 16
Metadata
- Authors
- Cadet, J. L., Jayanthi, S., & Deng, X.
- Affiliations
- National Institutes of Health (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 17
- Issue
- 13
- Pages
- 1775-1788
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2083351059
- Cited by
- 286
- References
- 212
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 13 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 8 · 2015: 10 · 2014: 12 · 2013: 10 · 2012: 14
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute on Drug Abuse
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methamphetamine, neurotoxicity, neuronal apoptosis, nerve terminal degeneration, monoaminergic systems, reactive oxygen species, transcription factors, cell death genes, endoplasmic reticulum stress, mitochondrial dysfunction, caspase activation
- MeSH terms
- Animals, Humans, Methamphetamine, Models, Biological, Nerve Degeneration, Neurons, Signal Transduction, Apoptosis, Presynaptic Terminals, Cytoprotection, Neurotoxicity Syndromes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review